A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

(2020) Haibo Zhang et al.   INTENSIVE CARE MEDICINE

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

SARS-CoV-2: a storm is raging

(2020) Savannah F. Pedersen et al.   JOURNAL OF CLINICAL INVESTIGATION

Endothelial cell infection and endotheliitis in COVID-19

(2020) Zsuzsanna Varga et al.   LANCET

Severe immune thrombocytopenia in a critically ill COVID-19 patient

(2020) Ziga Martincic et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients

(2020) Ming Tong et al.   JOURNAL OF INFECTIOUS DISEASES

Severe COVID-19 infection associated with endothelial activation

(2020) Robert Escher et al.   THROMBOSIS RESEARCH

A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm

(2020) Michael R Garvin et al.   eLife

Clinical, laboratory and radiological characteristics and outcomes of novel coronavirus (SARS-CoV-2) infection in humans: A systematic review and series of meta-analyses

(2020) Israel Júnior Borges do Nascimento et al.   PLoS One

Human recombinant soluble ACE2 in severe COVID-19

(2020) Alexander Zoufaly et al.   Lancet Respiratory Medicine

Integrity®bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience®everolimus-eluting stents in stable angina patients

(2016) Tibor Szük et al.   PLATELETS